The use of aminoglutethimide in the treatment of patients with metastatic carcinoma of the breast.
D000302:Adrenal Cortex / Q000187:drug effects / Q000378:metabolism; D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D000616:Aminoglutethimide / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D003907:Dexamethasone / Q000378:metabolism / Q000627:therapeutic use; D004347:Drug Interactions; D004965:Estrogen Antagonists / Q000627:therapeutic use; D004967:Estrogens / Q000097:blood; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism; D008593:Menopause; D009362:Neoplasm Metastasis; D010902:Pituitary Gland / Q000187:drug effects; D011960:Receptors, Estrogen / Q000032:analysis; D013961:Thyroid Gland / Q000187:drug effects
D000970:Antineoplastic Agents; D004965:Estrogen Antagonists; D004967:Estrogens; D011960:Receptors, Estrogen; D000616:Aminoglutethimide; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D006854:Hydrocortisone